Personalized Antisense Oligonucleotide for A Single Participant With UBTF Gene Mutation

Clinical trial NCT07588581 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07588581
Sponsor: n-Lorem Foundation
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Childhood-Onset Neurodegeneration With Brain Atrophy (CONDBA)

Start date: 2025-02-05
Primary completion: 2027-02-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.